Share
clock Created with Sketch.
08/03/21
17:31
Share
Originally posted by Rajenp5:
↑
During the AGM a shareholder asked why Virbac appeared to hogging the credit for Stelfonta, as there was not even a mention of Qbiotics on the label. It was a query that was swiftly deflected. Perhaps Qbiotics needs to take a lesson from the following, particularly as it is collaborating with Merck Pandion's secret to moving a $65M Merck offer to a $1.9B done deal in a year? Just keep saying no | FierceBiotech https://www.fiercebiotech.com/biotech/pandion-s-secret-to-moving-a-65m-merck-offer-to-a-1-9b-done-deal-a-year-just-keep-saying-no
Expand
one would hope the experience of 'ol mate' Rick Holliday-Smith ( cochlear) and 'new mate' Nicholas Moore ( MQG) to guide us to maximum offers if they where to eventuate